Skip to content

A prospective randomized controlled trial to evaluate omentum preserving gastrectomy for patients with cT1~T3 gastric cancer

A prospective randomized controlled trial to evaluate omentum preserving gastrectomy for patients with cT1~T3 gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040045
Enrollment
Unknown
Registered
2020-11-19
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer with stage cT1-T3

Interventions

Omentum-preserving group:Gastrectomy with omentum preserving
Complete-omentectomy group:Gastrectomy with omentum resection

Sponsors

Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) aged 18-75 years old; (2) The Eastern Cooperative Oncology Group (ECOG) physical status score =1 year; (8) Signing the informed consent.

Exclusion criteria

Exclusion criteria: (1) Suspected serosal or surrounding organ invasion (cT4); (2) Distant metastasis (including peritoneal metastasis, liver metastasis, lung metastasis, distant lymph node metastasis, etc.); (3) Remnant gastric cancer or gastric cancer recurrence; (4) Received preoperative radiotherapy or chemotherapy; (5) Bulky lymph nodes; (6) Emergency surgery; (7) Pregnant or lactating women; (8) Severe uncontrolled infection, or HIV infection; (9) Severe heart disease, myocardial infarction or unstable angina pectoris occurred within 6 months; (10) Uncontrolled diabetes; (11) Medical conditions that may or will definitely interfere with the research process (including follow-up and compliance).

Design outcomes

Primary

MeasureTime frame
Survival status;

Secondary

MeasureTime frame
Blood cell count;Serum biochemical test;Tumor markers for digestive system;Abdominal enhanced CT;Gastroscopy;

Countries

China

Contacts

Public ContactChao Yan

Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine

yanchaosuper@163.com+86 13681749682

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026